Skip to main content

Processa Pharmaceuticals, Inc.

corporate_fare Company Profile

Processa Pharmaceuticals, Inc.

PCSA·NASDAQ·Life Sciences·CIK 0001533743

Processa Pharmaceuticals, Inc. is a publicly listed clinical-stage biopharmaceutical company incorporated in Delaware on March 29, 2011. The company focuses on developing a pipeline of Next Generation Cancer therapy (NGC) small molecules. Their strategy involves identifying existing cancer therapies with well-understood mechanisms of action that are cornerstones of current treatment regimens but are highly toxic with treatment-limiting side effects. Processa then devises technologies to alter how the body metabolizes or distributes these therapies to enhance their therapeutic effect and reduce toxicity. The company develops its NGC therapies using its proprietary Regulatory Science Approach. Currently, one NGC small molecule is in a Phase 2 trial, while another is in pre-clinical development.

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for PCSA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 10/10, with 9 rated 8 or above. Recent SEC coverage for PCSA spans 10-Q, 8-K, PRE 14A, S-3.

Recent high-impact activity:

  • Processa 10-Q: $180.2M Cash but Going Concern Doubt Tied to Series A Conversion
  • Processa Letter Puts As-Converted Share Count at 309.3M vs 2.8M Trading
  • Processa Names Gujrathi Executive Chair, Adds Generian FcRn Program, Extends Runway to 2H 2029
  • FDA Clears IND for Processa's VT-7208 Phase 2 CSU Trial
  • Processa Seeks Reverse Split Approval to Meet Nasdaq $4.00 Listing Requirement

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$13.56M
Diluted EPS
-$10.36
Op. Cash Flow
-$11.39M
Operating Income
-$13.99M
Cash & Equivalents
$5.54M
Debt / Equity
0.00×
Shares Outstanding
2.57M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020731

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 26,138 shares in PCSA as of the October 30, 2026 settlement, a 43.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 30.6% of PCSA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)26,138 shares as of October 30, 2026
Change vs prior period▼ 43.8%
Days to cover1.00 at avg daily volume of 27,704
Daily short volume (FINRA facilities)30.6% of 24,337 shares on November 20, 2026
5-day average short volume31.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for PCSA, detected from its recent SEC filings.

1 shelf registration

306.6M Shares Registered for Resale · No Proceeds to Company

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with P →
$1.55 -0.64% today
52-week range · as of 2026-11-13 $1.04 – $8.88
Market cap
$4.37M
Volume
70.7K (1.6× avg)
3-mo avg 44.3K
Live data · 2026-11-21 18:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PCSA - Latest Insights

PCSA
Nov 13, 2026, 5:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.86
Real-time Price: $1.55 info
Change: -$0.310 (-17%) info
Market Cap: $4.365M info
PCSA
Nov 05, 2026, 8:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.85
Real-time Price: $1.55 info
Change: -$0.300 (-16%) info
Market Cap: $4.365M info
PCSA
Oct 29, 2026, 8:46 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.95
Real-time Price: $1.55 info
Change: -$0.400 (-21%) info
Market Cap: $4.365M info
PCSA
Oct 29, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.89
Real-time Price: $1.55 info
Change: -$0.340 (-18%) info
Market Cap: $4.365M info
PCSA
Oct 09, 2026, 4:03 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $1.55 info
Change: +$0.080 (+5%) info
Market Cap: $4.365M info
PCSA
Oct 09, 2026, 4:02 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $1.55 info
Change: +$0.080 (+5%) info
Market Cap: $4.365M info
PCSA
Oct 05, 2026, 7:21 AM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $1.60
Real-time Price: $1.55 info
Change: -$0.050 (-3%) info
Market Cap: $4.365M info
PCSA
Aug 14, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.43
Real-time Price: $1.55 info
Change: -$0.880 (-36%) info
Market Cap: $4.365M info
PCSA
Jul 29, 2026, 7:57 AM EDT
Source: Reuters
Importance Score:
10
Price at Filing: $2.27
Real-time Price: $1.55 info
Change: -$0.7201 (-32%) info
Market Cap: $4.365M info
PCSA
Jul 29, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $2.59
Real-time Price: $1.55 info
Change: -$1.04 (-40%) info
Market Cap: $4.365M info
PCSA
Jun 18, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.12
Real-time Price: $1.55 info
Change: -$0.570 (-27%) info
Market Cap: $4.365M info
PCSA
May 07, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.87
Real-time Price: $1.55 info
Change: -$1.32 (-46%) info
Market Cap: $4.365M info
PCSA
Apr 30, 2026, 5:14 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $1.55 info
Change: -$1.15 (-43%) info
Market Cap: $4.365M info
PCSA
Apr 30, 2026, 5:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $1.55 info
Change: -$1.15 (-43%) info
Market Cap: $4.365M info
PCSA
Feb 23, 2026, 11:00 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $2.09
Real-time Price: $1.55 info
Change: -$0.5367 (-26%) info
Market Cap: $4.365M info
PCSA
Feb 19, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.28
Real-time Price: $1.55 info
Change: -$0.730 (-32%) info
Market Cap: $4.365M info
PCSA
Jan 07, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.58
Real-time Price: $1.55 info
Change: -$2.03 (-57%) info
Market Cap: $4.365M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets